Systematic Review: Efficacy and Safety of Rituximab for Adults with Idiopathic Thrombocytopenic Purpura-Reference-Cited by-同舟云学术

Systematic Review: Efficacy and Safety of Rituximab for Adults with Idiopathic Thrombocytopenic Purpura

Published:2007-01-02 Issue:1 Volume:146 Page:25
ISSN:0003-4819
Container-title:Annals of Internal Medicine
language:en
Short-container-title:Ann Intern Med

Author:

Arnold Donald M.¹,Dentali Francesco¹,Crowther Mark A.¹,Meyer Ralph M.¹,Cook Richard J.¹,Sigouin Christopher¹,Fraser Graeme A.¹,Lim Wendy¹,Kelton John G.¹

Affiliation:

1. From McMaster University and Juravinski Cancer Centre, Hamilton, Ontario, Canada; Insubria University, Varese, Italy; National Cancer Institute of Canada Clinical Trials Group, Kingston, Ontario, Canada; Queen’s University, Kingston, Ontario, Canada; University of Waterloo, Waterloo, Ontario, Canada.

Publisher

American College of Physicians

Subject

General Medicine,Internal Medicine

Cited by 463 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long‐term complete remissions of refractory severe idiopathic immune thrombocytopenia treated with daratumumab: A case series;British Journal of Haematology;2024-07-28

2. Retrospective Evaluation of Survival and Prognostic Factors in Immune Thrombocytopenia: A Single-Center and Cross-Sectional Study;Medicina;2024-07-17

3. Fostamatinib for immune thrombocytopenic purpura in adult patients: A systematic review and meta‐analysis;eJHaem;2024-06-21

4. Rituximab as a treatment for refractory immune thrombocytopenia during pregnancy;Blood Coagulation & Fibrinolysis;2024-05-22

5. Rituximab Induced Rare Cystic Lesion in Lungs in a Nephrotic Child: A Case Report;Indian Journal of Nephrology;2024-05-09